Jazz Pharmaceuticals plc buy JPMorgan Chase & Co.
Start price
25.03.24
/
50%
€112.05
Target price
25.03.25
€175.31
Performance (%)
-8.26%
Price
26.07.24
€102.80
Summary
This prediction is currently active. With a performance of -8.26%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 25.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 2.646% | 2.646% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at JPMorgan Chase & Co. from $170.00 to $190.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.35
29.02.24
29.02.24
€157.28
28.02.25
28.02.25
-5.99%
26.07.24
26.07.24